{"id":"NCT00440037","sponsor":"Kyowa Kirin Co., Ltd.","briefTitle":"Open Label Extension Study of AMG 531 in Japanese Subjects With ITP","officialTitle":"An Open Label Extension Study Evaluating the Safety and Efficacy of Long Term Dosing of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-11","primaryCompletion":"2011-07","completion":"2011-09","firstPosted":"2007-02-26","resultsPosted":"2020-01-21","lastUpdate":"2020-01-21"},"enrollment":44,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Immune (Idiopathic) Thrombocytopenic Purpura (ITP)"],"interventions":[{"type":"BIOLOGICAL","name":"AMG 531","otherNames":["Romiplostim"]}],"arms":[{"label":"AMG 531","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and efficacy of long term dosing of AMG 531 in thrombocytopenic Japanese subjects with ITP.\n\nIt is anticipated that AMG 531 will be a safe and well tolerated in long term treatment and that AMG 531 will effectively raise and maintain platelet counts to a desired therapeutic range, when individual dose adjustments based on platelet counts are permitted.\n\nThis study is available to subjects who have completed any previous AMG 531 ITP study in Japan and meet the eligibility criteria of this study.","primaryOutcome":{"measure":"Percentage of Participants With Adverse Events Including Clinically Significant Changes in Laboratory Values.","timeFrame":"Through study completion, the median treatment duration (time between first dose and last dose) was 146.0 weeks (range: 12 to 243 weeks)","effectByArm":[{"arm":"AMG 531","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":13,"countries":["Japan"]},"refs":{"pmids":["23753021"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":44},"commonTop":["Nasopharyngitis","Headache","Back Pain","Contusion","Vertigo"]}}